Eli Lilly to seek U.S. emergency use for Covid-19 treatment
Microneedles for therapeutic gene delivery
Vir Biotechnology Kicks Off Covid-19 Treatment Trial; Shares Rise 6.1%
GSK and Vir expand COVID-19 antibody trial after Trump’s treatment with Regeneron’s rival
COVID-19 Outbreaks Worsen In NY, NJ & CT As Cuomo Outlines New Plan For Containing 'Hot Spots': Live Updates
If COVID-19 Antibody 'Cocktails' Become Popular, Sorrento Stock Could Double, Says Analyst
NYC Schools Close As COVID-19 Makes "Dangerous Comeback" Across US: Live Updates
The 6 Degrees of Separating Coronavirus from President Trump
Covid-19 roundup: Top analyst: Regeneron EUA likely this week — unless Trump takes a turn for worse; UK says less than half of residents will be vaccinated
Trump’s Treatments: Regeneron’s Antibodies and Gilead’s Remdesivir Explained
Airbnb nears IPO as Asana and Palantir land their direct listings
Gene Therapy’s Renaissance
Alone in the spotlight, Pfizer CEO Bourla swears pure intentions in the rush to develop a Covid-19 vaccine. But will the public believe it?
Amag Pops 45% On Covis Takeover Nod
3 "Strong Buy" Healthcare Stocks Under $5 That Could Go Boom
One small part of a human antibody has the potential to work as a drug for both prevention and therapy of COVID-19
Inovio: Despite COVID-19 Vaccine Headwinds, Core Value Drivers Remain Intact, Says 5-Star Analyst
BARDA boosts the fight against antibiotic-resistant infections with $144M awards
Goldman Sachs Predicts Over 40% Rally for These 3 Stocks
Oppenheimer: These 2 Stocks Are Poised to Surge by Over 100%
Evergreen Gavekal: Investors' Guide To The 2020 Election
Research on emerging COVID-19 (target, mechanism, and therapeutics)
Pandemic sets off future wave of worsening mental health issues
These 2 Penny Stocks Are Poised for a Massive Rally, Says Roth Capital
A Primer For The Media On Viruses, Vaccines, & COVID-19
Aquestive Plunges 37% As FDA Rejects Seizure Drug; Street Stays Bullish
Blueprint Nabs EU Green Light For Gastro Cancer Treatment
Clinical decision-making insights for haematologists and oncologists
Gilead’s Filgotinib Arthritis Drug Scores Europe, Japan Approval
Vertex or Galapagos: Which Biotech Stock Does The Street Favor?